EGFR and neoplasm: As recently reported by Molinari et al (2009), our observation confirms that primary CRC and paired metastasis may exhibit a difference with respect to the EGFR pathway; therefore, the analysis of metastatic sites should be considered, given that PTEN assessed on primary tumour might incompletely predict the response.